SFC
GILD icon

SYM Financial Corp’s Gilead Sciences GILD Stock Holding History

SYM Financial Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$495K Buy
3,550
+166
+5% +$23.2K 0.05% 132
2025
Q4 		$415K Buy
3,384
+144
+4% +$17.5K 0.04% 156
2025
Q3 		$360K Buy
3,240
+23
+0.7% +$2.61K 0.04% 172
2025
Q2 		$357K Buy
3,217
+1,318
+69% +$140K 0.04% 172
2025
Q1 		$213K Buy
+1,899
New +$196K 0.03% 251

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SYM Financial Corp's GILD Position: Q1 2026 in Review

SYM Financial Corp increased its Gilead Sciences (GILD) stake by 4.9% in Q1 2026, buying an estimated $23.2K and bringing the position to 3,550 shares worth $495K. The position accounts for 0.05% of the portfolio, ranked #132.

SYM Financial Corp first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • SYM Financial Corp held 3,550 shares of Gilead Sciences worth $495K as of Q1 2026.
  • SYM Financial Corp bought 166 Gilead Sciences shares in Q1 2026, an estimated $23.2K.
  • Gilead Sciences made up 0.05% of SYM Financial Corp's portfolio in Q1 2026, its #132 holding.
  • SYM Financial Corp first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SYM Financial Corp's 13F filing for Q1 2026, filed 8 May 2026.